For the Quarter Ending June 2026
Losartan Potassium Prices in APAC
- In China, the Losartan Potassium Price Index rose by 9.98% quarter-over-quarter, driven by export demand.
- The average Losartan Potassium price for the quarter was approximately USD 38933.33/MT per FOB assessments.
- Losartan Potassium Spot Price remained firm as exporters allocated prompt cargoes to the United States and Brazil.
- Losartan Potassium Price Forecast indicates moderate near-term gains followed by minor corrections as inventories normalize.
- Losartan Potassium Production Cost Trend shows environmental compliance pressure; potassium hydroxide costs remained broadly stable.
- Losartan Potassium Demand Outlook remains export-led with domestic procurement constrained currently by price-ceiling procurement policies.
- Losartan Potassium Price Index movement reflected balanced supply-demand; coastal operating rates and export enquiries aligned.
- Inventory accumulation at warehouses prompted sellers to channel material into export parcels, supporting offer discipline.
- Major coastal producers maintained high operating rates with environmental upgrades preventing compliance-related shutdowns and supply disruption.
Why did the price of Losartan Potassium change in June 2026 in APAC?
- Strong export enquiries absorbed surplus volumes while domestic price ceilings limited local procurement pressure.
- War-related solvent disruptions and rerouting extended transit times, elevating freight and insurance costs for exporters.
- Coastal plants ran at high operating rates; inventories remained manageable, allowing sellers to lift offers.
India
- In India, the Losartan Potassium Price Index rose by 3.36% quarter-over-quarter, driven by higher input and compliance costs.
- Losartan Potassium Production Cost Trend remained upward as tighter discharge rules and freight inflation increased conversion and intermediate expenses.
Losartan Potassium Prices in North America
- In the US, the Losartan Potassium Price Index trended upward quarter-over-quarter, driven by strong Asian export allocations and freight-linked landed-cost pressure.
- The Losartan Potassium price trend reflected firm FOB Asia values combined with elevated trans-Pacific freight and insurance costs.
- The Losartan Potassium Spot Price remained supported as exporters prioritized shipments to high-margin US and Brazil markets.
- The Losartan Potassium Price Forecast signals moderate gains followed by a slight correction once US inventories stabilize.
- The Losartan Potassium Production Cost Trend remained pressured by environmental compliance costs in China and stable potassium-based feedstock values.
- The Losartan Potassium Demand Outlook stayed strong, led by consistent pharmaceutical consumption and stable institutional procurement.
- Tightened Houston and West Coast inventories kept the Losartan Potassium Price Index firm, supporting seller confidence through June.
- Asian producers maintained high operating rates, but war-related rerouting and longer transit times elevated US landed-cost pressure.
Why did the price of Losartan Potassium change in June 2026 in North America?
- Strong export demand from Asia tightened prompt US availability, supporting firmer June Losartan offers.
- War-related rerouting and extended transit times raised freight and insurance, lifting June landed costs.
- Steady downstream pharmaceutical demand absorbed constrained volumes, enabling sellers to maintain firm June pricing.
Losartan Potassium Prices in Europe
- In Germany, the Losartan Potassium Price Index showed a firm upward trend quarter-over-quarter, supported by steady Asian export demand and disciplined European procurement.
- The Losartan Potassium price trend reflected stable FOB Asia offers combined with higher EU port-handling and compliance-related costs.
- The Losartan Potassium Spot Price remained firm as distributors prioritized structured purchasing and avoided speculative restocking amid tight regulatory oversight.
- The Losartan Potassium Price Forecast indicates moderate near-term firmness followed by slight correction as inventories normalize across major EU hubs.
- The Losartan Potassium Production Cost Trend remained elevated due to environmental compliance costs and stable potassium-based feedstock values.
- The Losartan Potassium Demand Outlook stayed steady, supported by consistent pharmaceutical formulation activity and predictable institutional procurement.
- Inventory discipline among German distributors kept the Losartan Potassium Price Index firm, with limited downside despite broader Asian supply stability.
- Asian producers maintained high operating rates, ensuring reliable supply, though longer transit times and insurance adjustments kept European landed-cost pressure elevated.
Why did the price of Losartan Potassium change in June 2026 in Europe?
- Strong Asian export demand tightened prompt availability, supporting firmer June Losartan offers into Germany.
- EU port-handling and compliance-related costs kept landed values elevated, sustaining June price firmness.
- Steady downstream pharmaceutical demand absorbed available volumes, limiting room for June price softening.
For the Quarter Ending March 2026
Losartan Potassium Prices in APAC
- In China, the Losartan Potassium Price Index fell by 2.70% quarter-over-quarter, reflecting weaker export demand.
- The average Losartan Potassium price for the quarter was approximately USD 35400.00/MT, indicating subdued buying.
- Losartan Potassium Spot Price firmed in March as export enquiries increased and bonded inventories tightened.
- Losartan Potassium Price Forecast expects modest post-March gains driven by export restocking and plant runs.
- Losartan Potassium Production Cost Trend remained contained as tetrazole and potassium-hydroxide feedstock prices stayed stable.
- Losartan Potassium Demand Outlook strengthened overseas with US and Brazil tender activity supporting contracted shipments.
- Losartan Potassium Price Index showed a March uptick as GMP re-qualification reduced available export-allocated capacity.
- Exporters discounted FOB offers to clear rising inventories, then raised quotes as bonded stocks declined.
Why did the price of Losartan Potassium change in March 2026 in APAC?
- GMP re-qualifications temporarily removed export-qualified lines, tightening supply and supporting firmer FOB offers in March.
- Front-loaded US and Brazilian tendering accelerated purchases, drawing down bonded inventories and strengthening export demand.
- Stable feedstock costs offered limited relief while compliance and shipping considerations kept producer offers elevated.
Losartan Potassium Prices in North America
- In the USA, the Losartan Potassium Price Index declined slightly quarter-over-quarter, reflecting earlier weak import demand and sufficient inventory coverage.
- Losartan Potassium Spot Price firmed in March as tightening export availability from China and increased tender-driven demand reduced immediate supply.
- Losartan Potassium Production Cost Trend remained stable, as upstream feedstock costs such as tetrazole and potassium hydroxide showed limited fluctuation.
- The Losartan Potassium Demand Outlook improved, supported by public health procurement programs and renewed buying interest from distributors.
- The Losartan Potassium Price Forecast modest near-term gains, driven by restocking cycles and constrained export supply.
- Inventory levels across US distribution channels tightened slightly as March procurement accelerated and replenishment lagged.
- Import dependence on Chinese suppliers exposed the market to supply disruptions caused by GMP-related capacity constraints.
- Suppliers adjusted pricing upward in March, following earlier discounts, as export demand strengthened and inventories declined.
Why did the price of Losartan Potassium change in March 2026 in North America?
- GMP-related production constraints in China reduced export availability, tightening the US supply.
- Increased procurement from healthcare tenders accelerated inventory drawdowns.
- Stable feedstock costs offered limited cost relief, allowing suppliers to raise prices amid stronger demand.
Losartan Potassium Prices in Europe
- In Germany, the Losartan Potassium Price Index showed a slight decline quarter-over-quarter, reflecting subdued early-quarter demand and adequate inventories.
- Losartan Potassium Spot Price strengthened in March as reduced export supply from China and improved demand tightened prompt availability.
- Losartan Potassium Production Cost Trend remained stable, supported by unchanged feedstock pricing and controlled upstream costs.
- The Losartan Potassium Demand Outlook improved, driven by steady pharmaceutical demand and tender-based procurement across Europe.
- The Losartan Potassium Price Forecast suggests mild upward movement, supported by restocking activity and constrained supply conditions.
- Inventory levels across European hubs declined slightly due to increased March purchasing and delayed replenishment.
- Import reliance on Asia made the market sensitive to GMP compliance disruptions affecting export-qualified capacity.
- Suppliers maintained firmer pricing in March, reflecting reduced availability and improving demand conditions.
Why did the price of Losartan Potassium change in March 2026 in Europe?
- GMP re-qualification in China reduced export-ready supply, tightening availability in Europe.
- Increased tender activity and restocking demand accelerated inventory drawdowns.
- Stable input costs allowed suppliers to pass through higher prices amid stronger demand and constrained supply.
For the Quarter Ending December 2025
APAC
- In China, the Losartan Potassium Price Index rose by 0.53% quarter-over-quarter, reflecting policy and supply adjustments recently.
- The average Losartan Potassium price for the quarter was approximately USD 36383.33/MT as reported by FOB Zhejiang.
- Balanced export bookings supported the Losartan Potassium Spot Price, while domestic procurement remained cautious and inventories were adequate.
- Short-term Losartan Potassium Price Forecast indicates mild corrections into year-end as traders prioritize inventory reduction measures.
- Stable raw material flows preserved the Losartan Potassium Production Cost Trend, limiting margin erosion despite export premiums.
- Dampened procurement under VBP influenced the Losartan Potassium Demand Outlook, keeping offtake steady but non-expansive during December.
- Monthly Price Index readings showed limited volatility as logistics remained smooth and coastal inventories stayed within targets.
- Producers maintained volumes to meet contracted shipments, preventing tightness while preserving export competitiveness and a steady realization period.
Why did the price of Losartan Potassium change in December 2025 in APAC?
- Exporters offered discounts to secure cargoes ahead of Lunar New Year logistics slowdown and softer spot demand.
- Feedstock stability and steady coal-based power costs prevented upward pressure despite reduced incremental export procurement during December.
- Mutual effects of VBP domestic price ceilings and prior forward coverages by buyers softened fresh buying interest.
Europe
- In Europe, the Losartan Potassium Price Index edged slightly higher quarter-over-quarter, influenced by import logistics and inventory adjustments.
- Losartan Potassium market conditions remained import-led, with Asian shipments supplying pharmaceutical distributors and hospital programs.
- Losartan Potassium Spot Price stayed stable as adequate port arrivals met routine procurement, keeping immediate pricing pressure limited.
- Short-term Losartan Potassium Price Forecast indicates mild correction into early 2026, as buyers manage inventories and plan year-end procurement.
- Losartan Potassium Production Cost Trend for importers remained steady, supported by stable feedstock and predictable freight costs.
- Dampened domestic tendering and procurement cycles kept the Losartan Potassium Demand Outlook balanced, with no significant expansion in offtake during December.
- Price Index volatility was limited, aided by smooth European port operations and consistent distributor stock levels.
- Importers maintained volumes to cover institutional and hospital requirements, avoiding tightness while preserving term contract competitiveness.
Why did the price of Losartan Potassium change in December 2025 in Europe?
- Sufficient Asian imports met routine demand, reducing urgency and moderating spot-price pressure.
- Stable feedstock and freight costs limited input-driven upward pressure on landed prices.
- Institutional buyers deferred incremental purchases near year-end, softening fresh demand.
North America
- In North America, the Losartan Potassium Price Index showed modest quarter-over-quarter firmness, influenced by stable import availability and cautious institutional buying.
- Losartan Potassium market conditions remained import-led, with India and China supplying most shipments for hospitals, distributors, and government programs.
- Losartan Potassium Spot Price stayed near monthly averages as distributors maintained adequate inventory, reducing urgency-driven pricing swings.
- Short-term Losartan Potassium Price Forecast signals mild corrections into early 2026, as buyers pace orders against anticipated restocking cycles.
- Losartan Potassium Production Cost Trend for importers remained broadly stable, with consistent feedstock pricing and predictable logistics maintaining landed-cost equilibrium.
- Demand Outlook stayed steady, with procurement from hospitals, pharmacies, and government health programs balancing seasonal consumption variations.
- Price Index readings reflected narrow movements, supported by stable port operations, timely customs clearance, and sufficient cargo arrivals.
- Importers managed volumes to meet contractual requirements, preventing tightness while allowing moderate spot flexibility.
Why did the price of Losartan Potassium change in December 2025 in North America?
- Stable export offers from India and China kept landed costs steady, limiting upward price pressure.
- Reduced year-end procurement softened immediate demand, moderating spot price activity.
- Predictable feedstock and shipping costs prevented cost-push, enabling importers to maintain competitive offers.
For the Quarter Ending September 2025
APAC
- In China, the Losartan Potassium Price Index fell by 2.66% quarter-over-quarter, due to high inventories.
- The average Losartan Potassium price for the quarter was approximately USD 50100.00/MT, FOB Zhejiang reported.
- Losartan Potassium Spot Price remained pressured while the Price Index reflected oversupply and weaker-than-expected procurement.
- Losartan Potassium Price Forecast indicates modest recovery as seasonal restocking and scheduled maintenance tighten availability.
- Losartan Potassium Production Cost Trend shows easing feedstock expenses, supporting pressure on producer margins recently.
- Losartan Potassium Demand Outlook remains muted as downstream pharmaceutical procurement stays cautious amid elevated stocks.
- Price Index shifts reflected accelerated stock clearance, weak export orders and sustained domestic production availability.
- Producers resumed operations after maintenance, but export demand softness and currency adjustments constrained price recovery.
Why did the price of Losartan Potassium change in September 2025 in APAC?
- Increased local availability after plant restarts elevated inventories, prompting sellers to lower export pricing aggressively.
- Subdued overseas procurement and tariff truce extension reduced forward buying, weakening international demand for shipments.
- Easing production input costs offset partly by rising freight and currency shifts, resulting in mixed net price pressure.
Europe
- In the Netherlands, the Losartan Potassium Price Index declined quarter-over-quarter, reflecting subdued import activity and stable inventory positions across major distributors.
- Losartan Potassium Spot Price remained under mild pressure as ample supply from Asian exporters and cautious European procurement limited transactional momentum.
- Losartan Potassium Price Forecast indicates a potential mild recovery in late months, supported by seasonal restocking and gradual stabilization in pharmaceutical manufacturing schedules.
- Losartan Potassium Production Cost Trend for importers eased, driven by lower API prices and favorable freight adjustments, marginally improving landed cost competitiveness.
- Losartan Potassium Demand Outlook stayed moderate, as consistent domestic formulations demand was offset by cautious purchasing behavior amid sufficient stock levels.
- The regional Price Index movement reflected balanced inventory management, steady logistics, and the availability of competitively priced Asian offers.
- Importers maintained disciplined buying patterns, focusing on minimizing overstocking while monitoring global API price movements.
- Stable shipping conditions and predictable supply from Asia helped maintain low volatility, although subdued demand limited upward price traction.
Why did the price of Losartan Potassium change in September 2025 in Europe?
- Competitive Asian export quotations reduced landed costs, putting downward pressure on European Losartan Potassium prices.
- Adequate domestic inventories and conservative procurement strategies among European buyers limited restocking activity and muted price increases.
- Softer input and freight costs further eased overall import expenses, supporting a mild decline in regional market prices.
North America
- In the USA, the Losartan Potassium Price Index declined quarter-over-quarter, influenced by weaker import quotations from Asian suppliers and adequate distributor inventories.
- Losartan Potassium Spot Price softened as abundant supply and cautious pharmaceutical procurement limited upward price movement.
- Losartan Potassium Price Forecast indicates mild recovery potential in Q4, supported by seasonal restocking and gradual downstream demand improvement.
- Losartan Potassium Production Cost Trend for importers eased as lower API prices and moderate freight adjustments reduced overall landed costs.
- Losartan Potassium Demand Outlook remained moderate, with conservative purchasing amid sufficient stocks across pharmaceutical distributors.
- Price Index movements reflected competitive Asian export offers, stable logistics, and controlled restocking activity from downstream users.
- Importers maintained disciplined buying patterns, minimizing overstocking while monitoring market and currency trends.
- Smooth shipping operations and steady Asian supply helped maintain low market volatility despite limited immediate demand increases.
Why did the price of Losartan Potassium change in September 2025 in North America?
- Softer Asian export offers and steady supply reduced landed import costs, contributing to a weaker Price Index.
- Sufficient inventories and cautious procurement from pharmaceutical manufacturers limited transactional activity and price recovery.
- Moderate freight costs and currency adjustments further eased import expenses, restraining any immediate upward pressure on pricing.
